ENVERIC BIOSCIENCES, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-12-31 was $19.34K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-09-30 was $58.65K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-06-30 was $9.25K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-03-31 was $619.03K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $4.82M.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $706.27K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $5.13M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2020-12-31 | $4.82M 10-K · filed 2022-03-31 | |
| 2018-12-31 | $19.34K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $706.27K 10-K · filed 2020-03-25 |
| 2018-09-30 | $58.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | |
| 2018-06-30 | $9.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2018-03-31 | $619.03K 10-Q · filed 2019-05-14 | |
| 2016-12-31 | $5.13M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |